Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
CYTK compared with ASND: revenue, margins and what each company keeps, and the suppliers and customers both name
CYTK
Cytokinetics Inc
Change
Mkt cap
Revenue
Revenue
ASND
Ascendis Pharma A/S
Change
Mkt cap
Revenue
Revenue
vs
Compare
CYTK
Cytokinetics Inc
vs
ASND
Ascendis Pharma A/S
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
CYTK, solid
ASND, dashed
CYTK
Cytokinetics Inc
Change
55.71
· pre 56.48
· delayed
Mkt cap
$7.7B
Revenue
$48M
Q3 FY26
Revenue
$88M
FY25
ASND
Ascendis Pharma A/S
Change
252.53
· pre 253.00
· delayed
Pre-market
Nov 6 '26
delayed
Mkt cap
$15.7B
Revenue
—
Revenue
—
vs
Compare
Pre-market
Nov 6 '26
delayed
CYTK
Cytokinetics Inc
vs
ASND
Ascendis Pharma A/S
55.71
pre 56.48
delayed
Price
252.53
pre 253.00
delayed
$7.7B
Mkt cap
$15.7B
Q3 FY26
$48M
Revenue
—
FY25
$88M
Revenue
—
Change
Change
CYTK
55.71
vs
ASND
252.53
Pre-market
Nov 6 '26
delayed